Search

everythinglearnresearchcommunity

for

Search:↓

New genetic insights have improved understanding of hair loss, leading to a new test and treatments, but more research is needed on the test and laser comb effectiveness.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Lespedeza cuneata extract may help treat enlarged prostate.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Finasteride side effects in young men may be linked to specific gene variations.

The T-zone on the face has more androgen receptors and produces more oil than the U-zone.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Analog 23 is a promising compound for prostate cancer treatment.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Combining scalp reduction and hair transplants improves coverage and appearance for male baldness.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

New compounds were made that are promising for prostate cancer therapy.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Walter P. Unger suggests using advanced hair transplant techniques for broader coverage, as they provide natural results and use donor tissue efficiently, while also recommending personalized planning due to the unpredictable progression of baldness.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.